Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 286696011000036111 | alemtuzumab 30 mg/mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 286698011000036110 | alemtuzumab 30 mg / 1 mL injection, 1 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| alemtuzumab 30 mg/mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| alemtuzumab 30 mg/mL injection, vial | Is a | alemtuzumab | true | Inferred relationship | Some | ||
| alemtuzumab 30 mg/mL injection, vial | has intended active ingredient | alemtuzumab | true | Inferred relationship | Some | 1891919438 | |
| alemtuzumab 30 mg/mL injection, vial | has Australian BoSS | alemtuzumab | true | Inferred relationship | Some | 1891919438 | |
| alemtuzumab 30 mg/mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| alemtuzumab 30 mg/mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1891919439 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Mabcampath 30 mg/mL injection, vial | Is a | True | alemtuzumab 30 mg/mL injection, vial | Inferred relationship | Some | |
| alemtuzumab 30 mg/mL injection, 3 x 1 mL vials | has MPUU | True | alemtuzumab 30 mg/mL injection, vial | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR